J&J began phasing out DePuy implants after FDA letter

The manufacturer of the recalled DePuy hip replacements began phasing out the implants after a Food and Drug Administration letter requested more safety studies on the device, according to internal company documents. Johnson & Johnson had previously insisted its 2010 recall of the DePuy ASR hip replacement was strictly a business decision and was not instigated by any FDA actions.

Click here to read more…

0 Responses to “J&J began phasing out DePuy implants after FDA letter”

  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 435 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.

%d bloggers like this: